|
COMMERCE BUSINESS DAILY ISSUE OF DECEMBER 20,1996 PSA#1746National Cancer Institute, Research Contracts Branch, PSCS 6120
Executive Blvd., EPS/634 Bethesda, Maryland 20892-7227 B -- MODULATION OF DRUG RESISTANCE: EFFLUX PHENOTYPES IN CHILDHOOD
LEUKEMIA SOL RFQ-70021-NS DUE 020597 POC Trish Haun, Contracting
Officer, 301/402-4509. The National Cancer Institute (NCI) intends to
enter into a three (3) year contract with the Children's National
Medical Center (CNMC), Washington, DC, to provide services associated
with a project entitled: "Modulation of Drug Resistance: Efflux
Phenotypes in Childhood Leukemia." This study will provide insight into
the biological mechanisms related to treatment failure. The incidence
and prevalence of resistance proteins that pump chemotherapy out of
leukemia cells will be evaluated by flow cytometry. This project will
study how common these drug resistance proteins are in childhood
leukemia, evaluate if their effect can be reversed and relate these
findings to initial response to treatment, relapse, long-term
relapse-free survival, and survival. The proposed work results from a
grant which was awarded by the American Cancer Society (ACS) to Dr. S.
Percy Ivy, formerly an Assistant Professor/Attending Physician, at
CNMC. Dr. Ivy has recently accepted a full time position with the NCI
and thisacquisition will provide a mechanism for conduct of the work
proposed. Dr Ivy's participation and technical direction of this
project is considered critical to the successful completion of the
work, as she is the Principal Investigator for the ACS grant. In
addition, the team and resources at CNMC, such as the Childrens Cancer
Group (CCG) Reference Laboratory, specified in the grant application
were also key factors in the peer review approval. This is not a
request for competitive solicitation. Organizations who wish to respond
to this notice must have their documentation at the following address
no later than 2:30 PM EST on 02/05/97 to Trish Haun, 6120 Executive
Boulevard, Room 634, Rockville, MD 20892-7227. No collect calls will be
accepted. (0353) Loren Data Corp. http://www.ld.com (SYN# 0012 19961220\B-0007.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|